Aspergillosis is a major cause of severe respiratory disease in birds. The prevalence of cryptic section Fumigati and other non-Aspergillus fumigatus species as causative agents is unknown. Species identity was determined in 30 isolates from affected birds from zoos, pet birds and poultry by PCR of the ITS1-5.8S-ITS2 and partial β-tubulin genes. The most prevalent isolate was A. fumigatus sens. str. in 87% (26) cases. Other Aspergillus species were identified in 13% (4) cases, including A. restrictus (1), A. flavus sens. str. (2), and A. nidulans-clade (1). This is the first report of A. restrictus causing avian disease.
Introduction
Avian aspergillosis, first reported in the 1800s, 1 is a significant cause of mortality among captive birds worldwide. It most commonly causes disease within the respiratory tract, and can progress to disseminated invasive aspergillosis. Two forms of lesions have been described; a granulomatous deep nodular form affecting non-aerated parenchyma, and a pyogranulomatous nonencapsulated superficial diffuse form involving lungs and serosae. 2 Captive birds are highly susceptible to aspergillosis due to environmental factors (increased burden of fungal spores), host immune factors (immunosuppression from disease, stress, or therapeutics), and unique respiratory anatomy.
1,2 Anatomical differences to mammals that enable unique airflow in birds include nonexpansile and unlobed lungs with no pleural cavity, looped parabronchi with bi-directional air flow capillaries instead of terminal ending alveoli, and cranial and caudal air sacs that extend the bronchial system beyond the lung to pneumatize bones and enable fresh airflow during inspiration and expiration. 3 Infection occurs when innate defenses cannot eliminate spores in parabronchial air capillaries, resulting in fungal plaques that can penetrate surrounding tissues. 2 Despite a range of antifungal therapeutic treatment options, infections are often fatal. 2 The clinical importance of fungal molecular identification techniques has been demonstrated for human and nonavian animal species with aspergillosis, with cryptic section Fumigati species increasingly identified, prompting epidemiological studies. [4] [5] [6] [7] [8] [9] We previously identified iso- 
Methods
Australian avian veterinarians were contacted to recruit isolates from clinical cases of avian aspergillosis between 2013 and 2017. Aspergillus isolates cultured from lesions in captive birds consistent with aspergillosis, including fungal plaques or granulomas observed within the respiratory tract or other parenchyma during diagnostic investigation or at post mortem were included for study. Morphological identification of Aspergillus species was performed by microbiologists, based on consistent macroscopic and microscopic features including identification of smooth or rough walled conidia stemming from radiate or columnar conidial heads with globose or subclavate vesicles, stipe and a foot cell. 11 Thirty isolates were received from Australian native and exotic avian species (Table 1) , including 26 from zoos (New South Wales [n = 23, Taronga Conservation Society approved opportunistic sampling request R14B178], South Australia [n = 3]), one from private practice (Queensland) and three from commercial poultry producers (NSW). Histopathology post-mortem reports were available for review in 20 zoological cases. All isolates were subcultured onto malt extract agar and grown in the dark at 25
• C for up to 7 days until sporulation occurred. DNA was extracted using the MoBio DNA isolation kit (QIAGEN MO BIO, Carlsbad, USA). Conventional polymerase chain reaction (PCR) was performed targeting the rDNA gene cluster, including the ITS1, 5.8S gene, and ITS2 regions using primers ITS1 and ITS4. 12 Amplification of the partial β-tubulin (BenA) gene was performed using primers bt2a and bt2b. 13 PCR product was sent to an external laboratory for purification and Sanger sequencing (Macrogen, Seoul, South Korea). Generated sequences were edited using BioEdit version 7.2.5. 14 Species identification was determined using NCBI-BLAST tool and sequence homology of ≥99% (ITS) and ≥99.5% (BenA) with type strains sequences. 15 If BenA homology was <99.5%, a separate alignment and phylogenetic analysis was performed in Mega 6.06 16 with sequences of all section typestrains to confirm the closest type-strain match using the maximum likelihood method based on the Tamura-Nei model with gamma distribution and 1000 bootstrap replicates. Sequences were deposited in GenBank (MF540250-MF540309).
Results
Twenty-six of 30 (87%) isolates were identified as A. fumigatus sens. str., and the remaining four (13%) were other Aspergillus species, including A. restrictus (n = 1), A. flavus sens. str. (n = 2), and A. nidulans-clade (n = 1) ( (1) .
Histopathology findings are summarized in supplementary Table 1 . Seventeen of 20 cases had invasive aspergillosis, which was disseminated in 12 and focal in five (respiratory). There were three cases of noninvasive localized infection, involving conjunctiva, air sacs, and a coelomic cavity mass. All six respiratory cases (5 invasive, 1 noninvasive) involved the lower respiratory tract; localized to the air sacs (1), the lungs (4), or both air sacs and lungs (1) . In four cases, a primary nonfungal disease process was identified including mycobacteriosis, egg yolk peritonitis, metastatic pancreatic adenocarcinoma and chronic liver disease.
Discussion
Aspergillus fumigatus sens. str. was the most common isolate amongst our study population (87%), similar to prevalence studies in humans, dogs, and the environment. [4] [5] [6] [7] [8] While other Aspergillus species were identified in 13% of cases, no cryptic section Fumigati species were identified. This is in contrast to prevalence studies in humans (0.75-3.7% of cases) [4] [5] [6] and reports on cats, in which invasive fungal rhinosinusitis is the most common form and is caused by cryptic species in section Fumigati. 9 Although our sample size was small, we found a similar prevalence for A. flavus sens. str. (6%) and A. nidulans-clade (3%) as is reported in humans (A. flavus 8-13%; A. nidulans 0.5-2.5%). [4] [5] [6] Our study is the first to our knowledge to report aspergillosis in birds due to A. restrictus. This case was in a Java Finch (Lonchura oryzivora) with chronic liver disease and disseminated invasive aspergillosis affecting air sacs, lung, and gizzard. Aspergillus restrictus has also been isolated from humans with disseminated infection following a heart valve replacement, although only phenotypic identification was performed. 17, 18 Our findings support an opportunistic pathogen role for this fungal species. This study demonstrates the value of molecular characterization of avian fungal isolates. Aspergillus species other than A. fumigatus sens. str. should also be considered as potential agents of this disease and may have important implications for patient management as seen in humans and other animals. Different Aspergillus species isolated from birds have been shown to have different susceptibilities to commonly used antifungal therapies, including itraconazole and amphotericin B. 19 This information could prove invaluable in management of a disease that is already challenged by lack of knowledge in avian pharmacokinetics and latestage clinical presentation. 2 We investigated avian aspergillosis amongst captive birds including several critically endangered native Australian species. The pathogenesis of avian disease has been associated with an increased environmental load of filamentous fungi in captive/rehabilitation settings (5.7% of fungal isolates grown) compared to natural avian habitats (0.03%), 20 with an A. fumigatus average air count nine times greater than natural habitats reported from rehabilitation centres. 21 Furthermore, genotyping of clinical and environmental isolates has demonstrated that the rehabilitation setting is a source of clinical disease in captive birds, likely due to this increased fungal burden and the presence of existing disease and/or stress. 21 This highlights the importance of environmental control strategies to reduce the risk of aspergillosis in captivity, and the importance of fungal load monitoring. Overall, the diversity of Aspergillus genus species causing infection in captive Australian birds was limited. Surveillance of wild birds may also be important for both human and animal health, as wild animal populations can be sentinels for infectious disease.
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Supplementary data are available at MMYCOL online.
